- Home
- CBIO vs EWCZ Comparison
CBIO vs EWCZ Comparison
Compare CBIO & EWCZ Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CBIO
- EWCZ
- Stock Information
- Founded
- CBIO 2003
- EWCZ 2004
- Country
- CBIO United States
- EWCZ United States
- Employees
- CBIO N/A
- EWCZ N/A
- Industry
- CBIO
- EWCZ Package Goods/Cosmetics
- Sector
- CBIO
- EWCZ Consumer Discretionary
- Exchange
- CBIO Nasdaq
- EWCZ Nasdaq
- Market Cap
- CBIO 308.0M
- EWCZ 239.2M
- IPO Year
- CBIO N/A
- EWCZ 2021
- Fundamental
- Price
- CBIO $12.60
- EWCZ $4.63
- Analyst Decision
- CBIO Strong Buy
- EWCZ Buy
- Analyst Count
- CBIO 3
- EWCZ 7
- Target Price
- CBIO $25.67
- EWCZ $5.86
- AVG Volume (30 Days)
- CBIO 138.8K
- EWCZ 397.5K
- Earning Date
- CBIO 08-23-2025
- EWCZ 08-13-2025
- Dividend Yield
- CBIO N/A
- EWCZ N/A
- EPS Growth
- CBIO N/A
- EWCZ N/A
- EPS
- CBIO N/A
- EWCZ 0.21
- Revenue
- CBIO N/A
- EWCZ $216,469,000.00
- Revenue This Year
- CBIO N/A
- EWCZ N/A
- Revenue Next Year
- CBIO N/A
- EWCZ $2.17
- P/E Ratio
- CBIO N/A
- EWCZ $22.63
- Revenue Growth
- CBIO N/A
- EWCZ N/A
- 52 Week Low
- CBIO $11.06
- EWCZ $2.72
- 52 Week High
- CBIO $21.40
- EWCZ $9.66
- Technical
- Relative Strength Index (RSI)
- CBIO N/A
- EWCZ 33.27
- Support Level
- CBIO N/A
- EWCZ $4.56
- Resistance Level
- CBIO N/A
- EWCZ $5.16
- Average True Range (ATR)
- CBIO 0.00
- EWCZ 0.19
- MACD
- CBIO 0.00
- EWCZ -0.06
- Stochastic Oscillator
- CBIO 0.00
- EWCZ 7.33
About CBIO Crescent Biopharma Inc. Common Stock
Crescent Biopharma Inc is a biopharmaceutical company developing novel therapeutics to treat solid tumors, led by CR-001, a proprietary anti-PD-1/anti-VEGF bispecific antibody. Crescent believes CR-001 has the potential to deliver improved clinical efficacy and safety over pembrolizumab. CR-001 is a new molecular entity designed to replicate the functional properties of ivonescimab, a cooperative bispecific anti-PD-1/anti-VEGF antibody in development by Akeso Biopharma and Summit Therapeutics that delivered improved efficacy in a head-to-head Phase 3 clinical trial versus Keytruda in non-small cell lung cancer. Crescent is advancing its second and third programs, CR-002 and CR-003, which are antibody drug conjugates (ADCs) against validated oncology targets.
About EWCZ European Wax Center Inc.
European Wax Center Inc is a franchisor and operator of OOH waxing services. Its product sales consist of revenue earned from sales of proprietary wax. Its services include Brazilian Waxing, Brow Waxing, Body Waxing, Facial Waxing, All Waxing Services, Eyebrow Tinting, Laser Hair Removal, Men's Waxing Services and others.